1-108722421-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001144937.3(FNDC7):āc.685T>Cā(p.Phe229Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000731 in 1,614,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001144937.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FNDC7 | NM_001144937.3 | c.685T>C | p.Phe229Leu | missense_variant | 5/13 | ENST00000370017.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FNDC7 | ENST00000370017.9 | c.685T>C | p.Phe229Leu | missense_variant | 5/13 | 5 | NM_001144937.3 | P1 | |
FNDC7 | ENST00000445274.1 | c.13T>C | p.Phe5Leu | missense_variant | 1/8 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000171 AC: 43AN: 251426Hom.: 0 AF XY: 0.000258 AC XY: 35AN XY: 135888
GnomAD4 exome AF: 0.0000773 AC: 113AN: 1461866Hom.: 0 Cov.: 34 AF XY: 0.000113 AC XY: 82AN XY: 727236
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.685T>C (p.F229L) alteration is located in exon 5 (coding exon 5) of the FNDC7 gene. This alteration results from a T to C substitution at nucleotide position 685, causing the phenylalanine (F) at amino acid position 229 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at